Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Daxor Corporation
DX5Current price
7.95 EUR
-0.55 EUR (-6.47%)
Last closed
9.23 USD
Company
www.daxor.com
ISIN
US2394671034
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
Frankfurt Exchange
Capitalization
45 835 368 USD
Yield for 12 month
+14.78 %
1Y
3Y
5Y
10Y
15Y
DX5
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh. Address: 109 Meco Lane, Oak Ridge, TN, United States, 37830
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
23.38 USDP/E ratio
8.1638Dividend Yield
–Current Year
+34 590 261 USD
Last Year
+6 310 294 USD
Current Quarter
+35 878 USD
Last Quarter
+35 878 USD
Current Year
+34 413 186 USD
Last Year
+6 310 294 USD
Current Quarter
-54 361 USD
Last Quarter
+35 878 USD
Key Figures DX5
1 year
3 years
5 years
10 years
EBITDA
–
Operating Margin TTM
PE Ratio
8.1638
Return On Assets TTM
-1.4 %
PEG Ratio
–
Return On Equity TTM
5.35 %
Wall Street Target Price
23.38 USD
Revenue TTM
154 205 USD
Book Value
6.75 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-11.4 %
Dividend Yield
–
Gross Profit TTM
231 641 USD
Earnings per share
1.16 USD
Diluted Eps TTM
1.16 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-57.6 %
Profit Margin
1094 %
Dividend Analytics DX5
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History DX5
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
05.01.2018
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
12.01.2018
Stock Valuation DX5
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
8.1638
Forward PE
–
Enterprise Value Revenue
18.2249
Price Sales TTM
297.2366
Enterprise Value EBITDA
–
Price Book MRQ
1.4036
Financials DX5
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators DX5
For 52 weeks
7.11 USD
10.04 USD
50 Day MA
9.04 USD
Shares Short Prior Month
15 861
200 Day MA
8.95 USD
Short Ratio
1.84
Shares Short
13 028
Short Percent
0.62 %
BeatStart